Sign in

You're signed outSign in or to get full access.

Gihyoun Bang

Chief Financial Officer at OSR Holdings
Executive

About Gihyoun Bang

Gihyoun (Chris) Bang is the Chief Financial Officer (Principal Financial Officer) of OSR Holdings, evidenced by his Sarbanes‑Oxley certifications on the Q1, Q2, and Q3 2025 Forms 10‑Q (signed May 20, 2025; August 14, 2025; and November 12, 2025) . Prior roles include VP at Newlake Alliance Management and Team Leader of the IPO Division at Shinhan Investment Corp, underscoring capital markets and listing execution experience . Compensation design emphasizes transaction-driven metrics rather than TSR/revenue/EBITDA, via the 2025 Omnibus Incentive Plan’s RSU Sub‑Plan that accelerates vesting upon business development deals reaching tiered contracted value thresholds ($300M–$1B) .

Past Roles

OrganizationRoleYearsStrategic Impact
Newlake Alliance ManagementVice PresidentNot disclosedNot disclosed
Shinhan Investment CorpTeam Leader, IPO DivisionNot disclosedNot disclosed

External Roles

OrganizationRoleYearsStrategic Impact
OSR Korea, Ltd.Representative Director2025 (signed 2025‑07‑24)Signatory to Woori IO transaction term sheet

Fixed Compensation

YearBase Salary ($)Stock Awards ($)Non‑Equity Incentive ($)All Other ($)Total ($)
202447,367 0 0 0 47,367
  • The proxy also states “None of our officers has received any cash compensation for services rendered to us… No officer or director has received any compensation for services rendered… during the year ended December 31, 2024,” creating an apparent inconsistency with the summary table above; OSR paid Bellevue Capital Management LLC $7,500 per month for office/admin support .

Performance Compensation

RSU Sub‑Plan (under 2025 Omnibus Incentive Plan)

Plan ElementTerms
Aggregate share reserve6,300,000 shares
RSU Sub‑Plan reserve3,150,000 shares (50% of aggregate)
Default vesting4‑year vesting with 1‑year cliff; monthly vesting over remaining 36 months
Accelerated vesting triggerUpon closing of a business development transaction with total contracted value thresholds
ClawbackSubject to any company clawback/recoupment/forfeiture policy
Contracted Value ThresholdAcceleration of Unvested RSUs
≥ $300M30% vests
≥ $500M50% vests
≥ $750M75% vests
≥ $1B100% vests

Named Executive Equity Awards

ExecutiveOutstanding Equity Awards (FY 2024 year‑end)
Gihyoun BangNone granted; no options or other equity compensation outstanding for FY 2023–2024

Change‑of‑Control Award Treatment (if awards not assumed/continued)

ScenarioTreatment
RSUs/Restricted Stock (time‑based)Deemed vested; shares/cash delivered immediately prior to CoC
Options/SARsBecome immediately exercisable for 15 days prior to CoC; may terminate post‑CoC; committee may cancel and pay cash/stock equal to deal consideration minus exercise price
Performance‑based awardsDetermined based on actual performance to date or treated as achieving target, at committee discretion; then settled per above

Equity Ownership & Alignment

As‑of DateBeneficial Shares OwnedOwnership %
August 15, 20250<1% (“*” less than one percent)
  • Outstanding equity awards at FY2024 year‑end: none for named officers including Bang .

Employment Terms

TermDetails
Employment AgreementNone for any member of management; no specific severance terms disclosed
Role confirmationCFO (Principal Financial Officer) certifications: Q1 2025 (May 20, 2025), Q2 2025 (Aug 14, 2025), Q3 2025 (Nov 12, 2025)
ClawbackRSU Sub‑Plan subject to company clawback/recoupment/forfeiture policy
Change‑of‑Control (awards not assumed)Time‑based RSUs vest; options/SARs become exercisable for 15 days; performance awards treated as actual/target at committee discretion

Say‑On‑Pay & Shareholder Feedback

ProposalForAgainstAbstain
Executive Compensation Proposal (Advisory)13,297,569 27,228 894
Equity Plan Proposal (2025 Omnibus sub‑plans)13,302,163 22,669 859
Nasdaq 20% Issuance Proposal13,288,524 36,490 677

Related Party & Governance Context

ItemDetails
Short‑term borrowings (as of Sept 30, 2025)BCM Europe AG (major shareholder): $860,000; Bellevue Global Life Sciences Acquisition Corp: $1,278,000
Key management compensation (nine months ended Sept 30)Salaries: $461,498 (2025) vs $283,050 (2024) – group level, not executive‑specific
Nasdaq minimum bid deficiency noticeReceived Sept 5, 2025; 180‑day window to regain compliance; potential reverse split if needed

Investment Implications

  • Alignment: Bang reported zero beneficial ownership (<1%) as of August 15, 2025, limiting “skin‑in‑the‑game” alignment absent new grants under the 2025 plan .
  • Retention/Contracts: No employment agreement or disclosed severance suggests organizational flexibility but may elevate retention risk unless equity incentives are granted under the Omnibus plan .
  • Incentive Design: RSU acceleration tied to large external business development deal values ($300M–$1B) prioritizes transactional milestones over TSR/operational metrics, potentially incentivizing deal closure speed and scale; clawback language exists but is policy‑contingent .
  • Change‑of‑Control Economics: Awards not assumed accelerate/settle around CoC, including 15‑day option exercise window and potential cash/stock payouts, which can create windfalls in sale scenarios (committee discretion), a classic single‑trigger risk for unassumed awards .
  • Shareholder Signals: Strong approvals for say‑on‑pay and equity plan enable equity issuance and incentives but also increase potential dilution via the Nasdaq 20% Issuance approval, relevant for future grant capacity and financing flexibility .
  • Trading/Execution Risk: Nasdaq bid‑price deficiency notice highlights capital market risk and possible reverse split, which can affect employee equity value expectations and insider selling pressure dynamics over time .